Previous studies have suggested that overexpression of survivin in CRC might serve as a prognostic factor but the direct relationship of survivin expression levels to clinicopathological variables and patients’ survival remains to be controversial. The gene discussed is BIRC5; the disease is colorectal carcinoma.